Effect of arctiin on glomerular filtration barrier damage in STZ-induced diabetic nephropathy rats

Phytotherapy Research

Volumn 27, Issue 10, 2013, Pages 1474-1480

  Ma, Song Tao ^a   Liu, Dong Lian ^a   Deng, Jing Jing ^a   Niu, Rui ^b   Liu, Rui Bin ^c  

^a CHENGDU MEDICAL COLLEGE   (China)

^b Chengdu Shangke Pharmaceutical Co Ltd   (China)

^c Chongqing Kerui Pharmaceutical Co   (China)

Author keywords

arctiin; diabetic nephropathy; glomerular filtration barrier; HPSE; nephrin; podocin

Indexed keywords

ALBUMIN; ARCTIIN; CAPTOPRIL; GLUCOSE; HEPARANASE; MESSENGER RNA; NEPHRIN; PODOCIN; STREPTOZOCIN;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; DRUG STRUCTURE; GENE EXPRESSION; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEPARANASE GENE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NEPHRIN GENE; NONHUMAN; PODOCIN GENE; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES;

ARCTIUM LAPPA; RATTUS;

ARCTIIN; DIABETIC NEPHROPATHY; GLOMERULAR FILTRATION BARRIER; HPSE; NEPHRIN; PODOCIN;

ALBUMINURIA; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; FURANS; GENE EXPRESSION REGULATION; GLOMERULAR FILTRATION BARRIER; GLUCOSIDES; GLUCURONIDASE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY GLOMERULUS; MALE; MEMBRANE PROTEINS; METABOLOME; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; STREPTOZOCIN;

EID: 84885633432     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4884     Document Type: Article

References (21)

1. Blum S, Nakhoul F, Khankin E, Abassi Z,. 2007. Renal slit diaphragm-the open zipper and the failing heart. Isr Med Assoc J 9: 107-111. (Pubitemid 46351253)
2. Doublier S, Salvidio G, Lupia E, et al,. 2003. Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II. Diabetes 52: 1023-1030. (Pubitemid 36384273)
3. Gray SP, Cooper ME,. 2011. Diabetic nephropathy in 2010: alleviating the burden of diabetic nephropathy. Nat Rev Nephrol 7: 71-73.
4. Hayashi K, Narutaki K, Nagaoka Y, Hayashi T, Uesato S,. 2010. Therapeutic effect of arctiin and arctigenin in immunocompetent and immunocompromised mice infected with influenza A virus. Biol Pharm Bull 33: 1199-1205.
5. Huang SL, Yu RT, Gong J, et al,. 2012. Arctigenin, a natural compound, activates AMP-activated protein kinase via inhibition of mitochondria complex I and ameliorates metabolic disorders in ob/ob mice. Diabetologia 5: 1469-1481.
6. Jarad G, Miner JH,. 2009. Update on the glomerular filtration barrier. Curr Opin Nephrol Hypertens 18: 226-232.
7. Lee JY, Kim CJ,. 2010. Arctigenin, a phenylpropanoid dibenzylbutyrolactone lignan, inhibits type I-IV allergic inflammation and pro-inflammatory enzymes. Arch Pharm Res 33: 947-957.
8. Lee S, Shin S, Kim H, et al,. 2011. Anti-inflammatory function of arctiin by inhibiting COX-2 expression via NF-ΰB pathways. J Inflamm (Lond) 8: 16.
9. Levidiotis V, Freeman C, Tikellis C, Cooper ME, Power DA,. 2004. Heparanase is involved in the pathogenesis of proteinuria as a result of glomerulonephritis. J Am Soc Nephrol 15: 68-78. (Pubitemid 38020699)
10. Masola V, Gambaro G, Tibaldi E, Onisto M, Abaterusso C, Lupo A,. 2011. Regulation of heparanase by albumin and advanced glycation end products in proximal tubular cells. Biochim Biophys Acta 1813: 1475-1482.
11. Matsuzaki Y, Koyama M, Hitomi T, et al,. 2008. Arctiin induces cell growth inhibition through the down-regulation of cyclin D1 expression. Oncol Rep 19: 721-727. (Pubitemid 351330441)
12. Pavenstädt H, Kriz W, Kretzler M,. 2003. Cell biology of the glomerular podocyte. Physiol Rev 83: 253-307. (Pubitemid 36459882)
13. Peti-Peterdi J, Sipos A,. 2010. A high-powered view of the filtration barrier. J Am Soc Nephrol 21: 1835-1841.
14. Schwarz K, Simons M, Reiser J, et al,. 2001. Podocin, a raftassociated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest 108: 1621-1629. (Pubitemid 33144872)
15. Szymczak M, KuÅ°niar J, Klinger M,. 2010. The role of heparanase in diseases of the glomeruli. Arch Immunol Ther Exp 58: 45-56.
16. Titan SM, Vieira J Jr, Dominguez WV, Barros RT, Zatz R,. 2011. ACEI and ARB combination therapy in patients with macroalbuminuric diabetic nephropathy and low socioeconomic level: a double-blind randomized clinical trial. Clin Nephrol 76: 273-283.
17. Tryggvason K,. 1999. Unraveling the mechanisms of glomerular ultrafiltration: nephrin, a key component of the slit diaphragm. J Am Soc Nephrol 10: 2440-2445. (Pubitemid 29501479)
18. Wagman AS, Nuss JM,. 2001. Current therapies and emerging targets for the treatment of diabetes. Curr Pharm Des 7: 417-450. (Pubitemid 32409729)
19. Weiss RB,. 1982. Streptozotocin: a review of its pharmacology, efficacy, and toxicity. Cancer Treat Rep 66: 427-438. (Pubitemid 12084932)
20. Wu JG, Wu JZ, Sun LN, et al,. 2009. Ameliorative effects of arctiin from Arctium lappa on experimental glomerulonephritis in rats. Phytomedicine 16: 1033-1041.
21. Yao X, Zhu F, Zhao Z, Liu C, Luo L, Yin Z,. 2011. Arctigenin enhances chemosensitivity of cancer cells to cisplatin through inhibition of the STAT3 signaling pathway. J Cell Biochem 112: 2837-2849.